Potential Milestone Year Ahead For Korean NASH Contenders

Hanmi Leads With US Phase II Trials

 
• By Jung Won Shin
  
NAFLD
Korean Firms Actively Pursuing NASH Drug Development In US Market • Source: Shutterstock

More from South Korea

More from Focus On Asia